Hopp til innhold
Klebsiella pneumoniae i blodkultur 2023
|
N
|
S
|
S%
|
I
|
I%
|
R
|
R%
|
Ampicillin
|
74
|
0
|
0,0%
|
0
|
0,0%
|
74
|
100%
|
Cefotaksim
|
74
|
67
|
90,5%
|
0
|
0,0%
|
7
|
9,5%
|
Ceftazidim
|
73
|
66
|
90,5%
|
2
|
2,5%
|
5
|
7%
|
Ciprofloksacin
|
72
|
63
|
87,5%
|
4
|
5,5%
|
5
|
7%
|
Gentamicin
|
73
|
71
|
97,5%
|
0
|
0,0%
|
2
|
2,5%
|
Meropenem
|
74
|
73
|
99%
|
1
|
1%
|
0
|
0,0%
|
Pip-tazo
|
74
|
69
|
93%
|
0
|
0,0%
|
5
|
7%
|
Trim-sulfa
|
73
|
63
|
86,5%
|
0
|
0,0%
|
10
|
13,5%
|
ESBL
|
|
|
|
|
|
6
|
8,1%
|
ESBL- karbapenemase
|
|
|
|
|
|
1
|
1,4%
|
Klebsiella pneumoniae blodkultur 2022
|
N |
S |
S% |
I |
I% |
R |
R% |
Ampicillin |
62 |
0 |
0,0 % |
0 |
0,0 % |
62 |
100,0 % |
Cefotaksim |
62 |
58 |
93,5 % |
1 |
1,6 % |
3 |
4,8 % |
Ceftazidim |
62 |
58 |
93,5 % |
1 |
1,6 % |
3 |
4,8 % |
Ciprofloksacin |
62 |
55 |
84,6 % |
3 |
4,6 % |
7 |
10,8 % |
Gentamicin |
62 |
61 |
98,4 % |
0 |
0,0 % |
1 |
1,6 % |
Meropenem |
62 |
62 |
100,0 % |
0 |
0,0 % |
0 |
0,0 % |
Pip-tazo |
62 |
58 |
93,5 % |
0 |
0,0 % |
4 |
6,5 % |
Trim-sulfa |
62 |
56 |
90,3 % |
1 |
1,6 % |
5 |
8,1 % |
ESBL |
|
|
|
|
|
4 |
6,5 % |
Klebsiella pneumoniae i blodkultur 2021
N |
S |
S% |
I |
I% |
R |
R% |
Ampicillin |
59 |
0 |
0% |
0 |
0% |
59 |
100% |
Cefotaxim |
59 |
57 |
96,6% |
0 |
0% |
2 |
3,4% |
Ceftazidim |
59 |
58 |
98,3% |
0 |
0% |
1 |
1,7% |
Ciprofloxacin |
59 |
55 |
93,2% |
0 |
0% |
4 |
6,8% |
Gentamicin |
59 |
57 |
96,6% |
0 |
0% |
2 |
3,4% |
Meropenem |
59 |
59 |
100% |
0 |
0% |
0 |
0% |
Pip-tazo |
59 |
57 |
96,6% |
2 |
3,4% |
0 |
0% |
Trim-sulfa |
59 |
54 |
91,5% |
0 |
0% |
5 |
8,5% |
ESBL |
|
|
|
|
|
2 |
3,4% |
Klebsiella pneumoniae i blodkultur 2020
N |
S |
S% |
I |
I% |
R |
R% |
Ampicillin |
43 |
0 |
0% |
0 |
0% |
43 |
100% |
Cefotaxim |
43 |
40 |
93% |
0 |
0% |
3 |
7,0% |
Ceftazidim |
43 |
39 |
90,7% |
3 |
7,0% |
1 |
2,3% |
Ciprofloxacin |
43 |
39 |
90,7% |
3 |
7,0% |
1 |
2,3% |
Gentamicin |
43 |
43 |
100% |
0 |
0% |
0 |
0% |
Meropenem |
43 |
43 |
100% |
0 |
0% |
0 |
0% |
Pip-tazo |
43 |
41 |
95,3% |
2 |
4,7% |
0 |
0% |
Trim-sulfa |
43 |
37 |
86% |
0 |
0% |
6 |
14,0% |
ESBL |
|
|
|
|
|
3 |
7,0% |